LD-2 disclosure · 3rd Quarter - Report
FOUNDATION MEDICINE, INC.
via FOUNDATION MEDICINE, INC.
Expenses$90Kself-filed spend
Client
- Name
- FOUNDATION MEDICINE, INC.
- Location
- Massachusetts · United States of America
Registrant
- Firm
- FOUNDATION MEDICINE, INC.
- Description
- Develop, manufacture and sell genomic analysis oncology diagnostics
- Location
- Boston, Massachusetts, United States of America
Lobbying activities
1 issueHealth Issues
- Diagnostic regulatory reforms, including the Verifying Accurate Leading-edge IVCT Development Act of 2023 (H.R.2369) and the pilot program for Oncology Drug Products Used with Certain In Vitro Diagnostic Tests
LobbyistsJENNIFER ROMANS
TargetedSENATE · HOUSE OF REPRESENTATIVES